Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
9,687
Value
$100.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RNAC by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,687$100.9K<0.1%−5,118−34.6%ReducedHolders
Q1 202614,805$91.1K<0.1%−8,489−36.4%ReducedHolders
Q4 202523,294$167.9K<0.1%+4,320+22.8%AddedHolders
Q3 202518,974$193.9K<0.1%−10,239−35.0%ReducedHolders
Q2 202529,213$303.5K<0.1%+11,363+63.7%AddedHolders
Q1 202517,850$235.3K<0.1%−6,412−26.4%ReducedHolders
Q4 202424,262$434.5K<0.1%+2,251+10.2%AddedHolders
Q3 202422,011$354.8K<0.1%+14,764+203.7%AddedHolders
Q2 20247,247$195.7K<0.1%−213,695−96.7%ReducedHolders
Q1 2024220,942$143.6K<0.1%−63,943−22.4%ReducedHolders
Q4 2023284,885$196.4K<0.1%+112,432+65.2%AddedHolders
Q3 2023172,453$182.8K<0.1%−80,978−32.0%ReducedHolders
Q2 2023253,431$283.8K<0.1%−14,951−5.6%ReducedHolders
Q1 2023268,382$373.1K<0.1%+124,995+87.2%AddedHolders
Q4 2022143,387$162.0K<0.1%+51,962+56.8%AddedHolders
Q3 202291,425$150.0K<0.1%−837,682−90.2%ReducedHolders
Q2 2022929,107$1.22M<0.1%+102,838+12.4%AddedHolders
Q1 2022826,269$1.02M<0.1%−463,099−35.9%ReducedHolders
Q4 20211,289,368$4.20M<0.1%+804,353+165.8%AddedHolders
Q3 2021485,015$2.02M<0.1%+1550.0%AddedHolders
Q2 2021484,860$2.03M<0.1%−337,206−41.0%ReducedHolders
Q1 2021822,066$3.72M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.